Anesthesiology

Sleep Apnea Feature

Samsung Electronics Co., Ltd

FDA-cleared AI medical device

An over-the-counter device to assess risk of sleep apnea is intended to provide a notification of the risk of sleep apnea in users who have not been previously diagnosed with sleep apnea. This device uses software algorithms to analyze input sensor signals and provide a risk assessment for sleep apnea. It is not intended to provide a standalone diagnosis, replace traditional methods of diagnosis (e.g., polysomnography), assist clinicians in diagnosing sleep disorders, or be used as an apnea monitor.

FDA Submission Metadata

Submission number
DEN230041
Decision date
February 2024
FDA panel
Anesthesiology
Product code
QZW
Clinical task (npj)
diagnosis
Data modality (npj)
Signals

This entry is sourced from the FDA AI/ML-Enabled Medical Devices list. No editorial review yet — the catalogue may add a deeper review of this device in future.

View on FDA ›

This entry is on our editorial review queue. Full evaluation — performance metrics, clinical evidence, safety record — lands as our review pipeline graduates each device. The information above is what's been verified to date.